Clinical Trial Update: Effect of Saxagliptin Treatment on Myocardial Fat Content, and Monocyte Inflammation [Phase 4]

View source ↗

Summary

Phase 4 clinical trial examining the effect of saxagliptin on myocardial fat content and monocyte inflammation in impaired glucose tolerance; study terminated w…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Impaired Glucose Tolerance

Drugs mentioned

• Saxagliptin (saxagliptin)

Snippet

Sponsor: Baylor College of Medicine | Conditions: Impaired Glucose Tolerance | Phase 4 | Status: TERMINATED | Results posted: 2020-01-13